Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Puneet Souda from Leerink Partners maintained a Buy rating on the stock and has ...

In recent trading, Agilent Technologies Inc (A) stock price has shown some volatility, fluctuating 5.96% over the last five trades and 3.30% over the past 30 trades. This represents a notable shift ...

Throughout the last three months, 4 analysts have evaluated Agilent Technologies A +0.10% Get Free Report , offering a ...

Agilent (A – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Michael Ryskin from ...

Agilent Technologies announced reorganization into three business units: life sciences and diagnostics led by Simon May, ...

I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic ...

Q4 2024 Earnings Call Transcript November 25, 2024 Agilent Technologies, Inc. beats earnings expectations. Reported EPS is $1 ...

Medical equipment makers such as Agilent are seeing soft demand from early-stage biotechs, as these smaller drug development ...

Shares of Texas Pacific Land have roughly tripled in 2024 despite languishing oil prices, thanks to a new approach the 100-employee firm has taken to wringing money from its acres in America's most ...

Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.70 billion for the fourth quarter ended October 31, 2024, an increase of 0.8% reported and a ...

The company said that gains in its Agilent CrossLab Group offset losses across its other two divisions as the company undertakes restructuring to grow as the market improves.

Agilent Technologies, a leading provider of life sciences and applied markets solutions, has taken a significant step forward ...